临床医药实践
臨床醫藥實踐
림상의약실천
PROCEEDING OF CLINICAL MEDICINE
2014年
8期
587-589
,共3页
姚枫%范静%黄艳芳%马俊华%胡建修%魏隽
姚楓%範靜%黃豔芳%馬俊華%鬍建脩%魏雋
요풍%범정%황염방%마준화%호건수%위준
复发性子宫肌瘤%介入治疗%疗效
複髮性子宮肌瘤%介入治療%療效
복발성자궁기류%개입치료%료효
recurrenthysteromyoma%interventionaltherapy%curativeeffect
目的:评价子宫动脉栓塞治疗术后复发性子宫肌瘤的可行性和有效性,探索复发性子宫肌瘤的治疗方法。方法:采用回顾性研究方法分析40例子宫肌瘤剜除术后复发性子宫肌瘤接受了双侧子宫动脉栓塞治疗后的临床效果及术后随访结果。结果:所有病例术后随访12个月。术后3个月、6个月及12个月的临床症状改善率分别为80%,84%和90%。肌瘤平均缩小率为22.7%,46.2%和70.5%。术后12个月子宫体积平均缩小率为63.7%。40例术后均无严重并发症。结论:对于子宫肌瘤剜除术后复发性子宫肌瘤患者,子宫动脉栓塞术是一种安全有效的微创治疗手段。
目的:評價子宮動脈栓塞治療術後複髮性子宮肌瘤的可行性和有效性,探索複髮性子宮肌瘤的治療方法。方法:採用迴顧性研究方法分析40例子宮肌瘤剜除術後複髮性子宮肌瘤接受瞭雙側子宮動脈栓塞治療後的臨床效果及術後隨訪結果。結果:所有病例術後隨訪12箇月。術後3箇月、6箇月及12箇月的臨床癥狀改善率分彆為80%,84%和90%。肌瘤平均縮小率為22.7%,46.2%和70.5%。術後12箇月子宮體積平均縮小率為63.7%。40例術後均無嚴重併髮癥。結論:對于子宮肌瘤剜除術後複髮性子宮肌瘤患者,子宮動脈栓塞術是一種安全有效的微創治療手段。
목적:평개자궁동맥전새치료술후복발성자궁기류적가행성화유효성,탐색복발성자궁기류적치료방법。방법:채용회고성연구방법분석40례자궁기류완제술후복발성자궁기류접수료쌍측자궁동맥전새치료후적림상효과급술후수방결과。결과:소유병례술후수방12개월。술후3개월、6개월급12개월적림상증상개선솔분별위80%,84%화90%。기류평균축소솔위22.7%,46.2%화70.5%。술후12개월자궁체적평균축소솔위63.7%。40례술후균무엄중병발증。결론:대우자궁기류완제술후복발성자궁기류환자,자궁동맥전새술시일충안전유효적미창치료수단。
Toevaluatethesafetyandcurativeeffectoftranscatheteruterinearterialembolizationintreatment of recurrent hysteromyoma,to poke the treatemnt of recurrent hysteromyoma. Methods:Performing retrospective study on 40 pa-tients suffering from recurrent hysteromyoma after myomectomy and treated by using transcatheter uterine arterial embolization. These patients were followed up for 3 to 12 mouths postoperatively. Results:The symptom improved rates after operation 3 months,6 months and 12 months were 80%,84% and 90%,respectively. The sizes of hysteromyomas were lessened,with rates of 22. 7%,46. 2% and 70. 5% respectively after these periods,so were the uteruses with the rate of 63. 7%. The clinical symptoms were improved and without severe complications postoperatively. Conclusion:It is an safe and effective method to treat recurrent hysteromyoma by using transcatheter uterine arterial embolization.